Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris

被引:65
|
作者
Jin, Ye [1 ]
Meng, Xue [1 ]
Qiu, Zhidong [1 ]
Su, Yanping [2 ]
Yu, Peng [1 ]
Qu, Peng [3 ]
机构
[1] Changchun Univ Chinese Med, Dept Pharm, 1035 Boshuo Rd, Changchun 130117, Jilin, Peoples R China
[2] Taishan Med Coll, Dept Histol & Embryol, Tai An, Shandong, Peoples R China
[3] NCI, NIH, Frederick, MD 21702 USA
基金
中国国家自然科学基金;
关键词
Cordycepin; Anti-tumor; Anti-metastasis; GALLBLADDER CANCER-CELLS; STEM-CELLS; APOPTOSIS; METASTASIS; MELANOMA; INVASION; PATHWAY; ARREST; CYCLE; ANGIOGENESIS;
D O I
10.1016/j.sjbs.2018.05.016
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Public interest in complementary and alternative medicine has been increased worldwide, due to its wide applications in cancer prevention and treatment. Cordycepin is one of the most common and crucial types of complementary and alternative medicine. Cordycepin (3'-deoxyadenosine), a derivative of adenosine, was first isolated from medicine drug Cordyceps militaris. Cordycepin has been widely used as one compound for antitumor, which has been found to exert antiangiogenic, anti-metastatic, and antiproliferative effects, as well as inducing apoptosis. However, the mechanism of its anti-tumor activity is not well known. This review will clarify anti-tumor mechanisms of Cordycepin, which regulate signaling pathways related with tumor growth and metastasis. Cordycepin inhibit tumor growth via upregulating tumor apoptosis, inducing cell cycle arrest and targeting cancer stem cells (CSCs). Cordycepin regulates tumor microenvironment via suppressing tumor metastasis-related pathways. Thus, Cordycepins may be one of important supplement or substitute medicine drug for cancer treatment. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:991 / 995
页数:5
相关论文
共 50 条
  • [41] NAFAZATROM - PHASE-I TRIAL OF A NEW ANTI-METASTATIC COMPOUND
    WARRELL, RP
    BOCKMAN, RS
    STASZEWSKI, H
    MAIESE, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 357 - 357
  • [42] Tumor-associated antigen peptides as anti-metastatic vaccines
    Lea Eisenbach
    Ofer Mandelboim
    Erez Bar-Haim
    Lior Carmon
    Hernan Copcow
    Khaled El-Shami
    Adrian Paz
    Dan Popovic
    Ezra Vadai
    Esther Tzehoval
    Michael Feldman
    Mati Fridkin
    Letters in Peptide Science, 1998, 5 : 323 - 328
  • [43] Tumor-Associated Antigen Peptides as Anti-Metastatic Vaccines
    Lea Eisenbach
    Ofer Mandelboim
    Erez Bar-Haim
    Lior Carmon
    Hernan Copcow
    Khaled El-Shami
    Adrian Paz
    Dan Popovic
    Ezra Vadai
    Esther Tzehoval
    Michael Feldman
    Mati Fridkin
    Letters in Peptide Science, 1998, 5 : 323 - 328
  • [44] Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties
    Lapierre, F
    Holme, K
    Lam, L
    Tressler, RJ
    Storm, N
    Wee, J
    Stack, RJ
    Castellot, J
    Tyrrell, DJ
    GLYCOBIOLOGY, 1996, 6 (03) : 355 - 366
  • [45] Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
    Randelovic, Ivan
    Schuster, Sabine
    Kapuvari, Bence
    Fossati, Gianluca
    Steinkuehler, Christian
    Mezo, Gabor
    Tovari, Jozsef
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [46] Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity
    Cornelius, Peter
    Mayes, Benjamin A.
    Petersen, John S.
    Turnquist, David J.
    Dufour, Pierre J.
    Dannenberg, Andrew J.
    Shanahan, James M.
    Carver, Bradley J.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (05) : 595 - 605
  • [47] Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo
    Yingqi Hua
    Zhiyu Zhang
    Jianxin Li
    Quan Li
    Shuo Hu
    Jian Li
    Mengxiong Sun
    Zhengdong Cai
    Investigational New Drugs, 2011, 29 : 258 - 265
  • [48] Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo
    Hua, Yingqi
    Zhang, Zhiyu
    Li, Jianxin
    Li, Quan
    Hu, Shuo
    Li, Jian
    Sun, Mengxiong
    Cai, Zhengdong
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 258 - 265
  • [49] Delivery of the Bioactive Component Paeonol by Dual pH-Responsive Nanoparticles Enhances Anti-Metastatic Tumor Efficiency
    Liu, Haiting
    Li, Jian
    Shang, Yinghui
    Zhao, Qiangqiang
    Wu, Bin
    Huang, Xueyuan
    Dong, Hang
    Gui, Rong
    Huang, Rong
    CHEMNANOMAT, 2021, 7 (01) : 50 - 60
  • [50] Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice
    Lee, Gee Young
    Park, Kyeongsoon
    Nam, Jong Hee
    Kim, Sang Yoon
    Byun, Youngro
    JOURNAL OF DRUG TARGETING, 2006, 14 (10) : 707 - 716